FDA PMA FDA Class 3 Approved 🇺🇸 United States

Kit, Test, Alpha-Fetoprotein For Neural Tube Defects

PMA: P980041 · Supplement: S001 · Decision Oct 1, 2002
Classifications
1
FEI Numbers
9
Registration Numbers
9

Basic Information

Device Name
Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
Trade Name
ACCESS AFP ASSAY ON THE ACCESS 2 IMMUNOASSAY SYSTEMS
PMA Number
P980041
Supplement Number
S001
Device Class
FDA Class 3
Product Code
LOK
Generic Name
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Medical Specialty
Unknown
Advisory Committee
Immunology
Decision
Approved
Decision Code
APPR
Decision Date
October 1, 2002
Date Received
June 18, 2002
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR EXPANDING THE USE OF THE AFP IMMUNOASSAY ON THE ACCESS 2 ANALYZER. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADENAME ACCESS AFP IMMUNOASSAY SYSTEM AND IS INDICATED FOR THE QUANTITATIVE DETERMINATION OF ALPHA-FETOPROTEIN (AFP) IN: 1) HUMAN SERUM, AS AN AID IN THE MANAGEMENT OF PATIENTS WITH NON-SEMINOMATOUS TESTICULAR CANCER. 2) MATERNAL SERUM AND AMNIOTIC FLUID AT 15 TO 20 WEEKS GESTATION, TO AID IN THE DETECTION OF FETAL OPEN NEURAL TUBE DEFECTS (ONTD). TEST RESULTS, WHEN USED IN CONJUNCTION WITH ULTRASONOGRAPHY, ARE SAFE AND EFFECTIVE AIDS IN THE DETECTION OF FETAL ONTD. THE ASSAY IS INTENDED FOR USED IN CONJUNCTION WITH OTHER DIAGNOSTIC TOOLS SUCH AS ULTRASOUND AND AMNIOGRAPHY.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOK Kit, Test, Alpha-Fetoprotein For Neural Tube Defects